SOLV - Multiplikator Forward P/S Solventum
Strict FDA oversight and lobbying create significant barriers to entry for new players, yet Solventum Corporation (SOLV) robotic lines minimize labor costs. The company's forward P/S valuation on the GURU.Markets chart resolves this contrast, with the value fixed at 0.20. Business stability relies on a massive patent portfolio, which makes switching medical consumables virtually impossible.
Rincian metrik lan analitis perusahaan Solventum Health (SOLV)
- rega saham lan target rega konsensus:
- statistik kapitalisasi pasar:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Solventum Corporation|SOLV - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Solventum Corporation|SOLV - Gunggung utang perusahaan|Utang marang nilai buku Solventum Health|SOLV - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Solventum|Likuiditas cepet solventum.com
- data bathi bisnis lan rasio investasi:
SOLV - Penghasilan resik perusahaan|Bathi sing dikarepake Solventum Corporation|SOLV - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep Solventum Inc.|SOLV - Rasio kapitalisasi marang bathi lan wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Solventum Health|SOLV - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Solventum|SOLV - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan solventum.com|SOLV - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Solventum Corporation
- indikator dodolan lan pendapatan:
Analisis kabeh metrik perusahaan:Solventum (SOLV)
Solventum Corporation (SOLV) maintains resilience against market downturns due to stable clinic demand for proven medical consumables. Regular multi-million dollar procurements of core products create a predictable cash flow, reducing business volatility. By analyzing the forward P/S multiple, an investor assesses the company's current valuation relative to expected revenue to determine if the asset is overbought based on Wall Street consensus forecasts.
Pesaing wigati
HCA Healthcare - Multiplikator forward rega marang pendapatan|Tenet Healthcare Corp - Rasio rega marang prakiraan pendapatan|Fresenius Medical Care Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Encompass|uhsinc.com (UHS) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan DVA|Multiplikator forward rega marang pendapatan RDNT|OPCH (Option Care) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan SGRY (Surgery Partners Corp)|Multiplikator Forward P/S Premier Health (PINC)|Rasio rega marang prakiraan pendapatan National Vision Holdings EYE|PGNY - Multiplikator forward rega marang pendapatan|ARDT: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SEM (Select Medical Corporation)|ASTH: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan MEDNAX|Rasio rega marang prakiraan pendapatan US Physical Therapy|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep pennantgroup.com PNTG|Rasio rega marang prakiraan pendapatan Organogenesis (ORGO)|NUTX (Nutex Health Inc) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Auna Health AUNA|SBC (SBC Medical Group Holdings) - Rega mangsa ngarep marang pendapatan|EOLS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep chs.net|beautyhealth.com (SKIN) - Rasio rega marang prakiraan pendapatan|MediWound - Rega forward marang dodolan|BTMD (Biote Corp) - Multiplikator Forward P/S|Multiplikator Forward P/S The Joint|Multiplikator forward rega marang pendapatan DCGO (DocGo Inc.)|Rasio rega marang pendapatan sing dikarepake PIII|Multiplikator Forward P/S GANX (Gain Therapeutics)|Rasio kapitalisasi marang dodolan sing dikarepake EUDA Health Holdings (EUDA)|BMGL - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CollPlant Biotechnologies|Cuprina Holdings (Cayman) Ltd (CUPR) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan CCM|Rasio rega marang prakiraan pendapatan American Shared Hospital Services|MEDIROM Healthcare Group Inc. (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Avalon GloboCare (ALBT)|DHAI - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Longevity Health Holdings XAGE|newgenivf.com - Rasio rega marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CMAX: Rasio rega marang prakiraan pendapatan|KDLY (Kindly MD Corp) - Multiplikator forward rega marang pendapatan|MODV: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences|SSY: Rega forward marang dodolan|Multiplikator Forward P/S BACK
